GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Direxion Daily S&P Biotech Bear 3X ETF Forecast

$10.52
+0.440 (+4.37%)
At Close: Apr 18, 2024
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LABD
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Direxion Daily S&P Biotech Bear 3X
(Updated on Apr 18, 2024)

Buy candidate since Apr 12, 2024 Gain 17.15% PDF

The Direxion Daily S&P Biotech Bear 3X ETF price gained 4.37% on the last trading day (Thursday, 18th Apr 2024), rising from $10.08 to $10.52. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the ETF fluctuated 5.59% from a day low at $10.01 to a day high of $10.57. The price has risen in 6 of the last 10 days and is up by 22.04% over the past 2 weeks. Volume fell on the last day by -123 thousand shares and in total, 15 million shares were bought and sold for approximately $162.37 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the ETF is expected to fall -10.68% during the next 3 months and, with a 90% probability hold a price between $4.62 and $9.40 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LABD Signals & Forecast

Mostly positive signals in the chart today. The Direxion Daily S&P Biotech Bear 3X ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.35 and $7.75. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, February 27, 2024, and so far it has risen 78.31%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The ETF should be watched closely.

Support, Risk & Stop-loss for Direxion Daily S&P Biotech Bear 3X ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $9.90 and $9.77. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, Direxion Daily S&P Biotech Bear 3X finds support just below today's level at $9.90. If this is broken, then the next support from accumulated volume will be at $9.77 and $9.47.

This ETF may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this ETF is considered to be "high risk". During the last day, the ETF moved $0.560 between high and low, or 5.59%. For the last week, the ETF has had daily average volatility of 7.67%.

The Direxion Daily S&P Biotech Bear 3X ETF is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some ETFS may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the ETF manages to break the trend before that occurs.

Our recommended stop-loss: $10.21 (-2.90%) (This ETF has high daily movements and this gives high risk. The RSI14 is 80 and this increases the risk substantially. There is a buy signal from a pivot bottom found 36 days ago.)

Trading Expectations (LABD) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Direxion Daily S&P Biotech Bear 3X ETF to open at $10.37, and during the day (based on 14 day Average True Range), to move between $9.89 and $11.15, which gives a possible trading interval of +/-$0.628 (+/-5.97%) up or down from last closing price. If Direxion Daily S&P Biotech Bear 3X ETF takes out the full calculated possible swing range there will be an estimated 11.95% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $9.90, some $0.620 (5.89%) from the current price of $10.52, our system finds the risk reward attractive.

Is Direxion Daily S&P Biotech Bear 3X ETF ETF A Buy?

Several short-term signals are positive, despite the ETF being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for ETF to perform well in the short-term.

Current score: 4.750 Buy Candidate Unchanged

Predicted Opening Price for Direxion Daily S&P Biotech Bear 3X ETF of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$10.37 ( 1.46%) $10.52

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LABD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 10.93 3.87 %
R2 10.71 1.83 %
R1 10.58 0.576 %
Current price: 10.52
Support S1 10.15 -3.49 %
S2 10.02 -4.75 %
S3 9.81 -6.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 10.52
Support S1 9.90 -5.89%
S2 9.77 -7.13%
S3 9.47 -9.98%

LABD Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 18, 2024 Mar 19, 2024 Mar 26, 2024 $0.0664 0.85%
2 Dec 21, 2023 Dec 21, 2023 Dec 21, 2023 $0.0850 0.742%
3 Mar 23, 2023 Sep 19, 2023 Sep 26, 2023 $0.192 0.94%
4 Mar 23, 2023 Jun 21, 2023 Jun 28, 2023 $0.100 0.714%
5 Mar 20, 2023 Mar 21, 2023 Mar 28, 2023 $0.218 0.99%

FAQ

What is the symbol for Direxion Daily S&P Biotech Bear 3X ETF ETF and on which exchange is it traded?
The symbol for Direxion Daily S&P Biotech Bear 3X ETF is LABD and it is traded on the NYSEARCA (NYSE Arca).

Should I buy or sell Direxion Daily S&P Biotech Bear 3X ETF ETF?
Several short-term signals are positive, despite the ETF being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for ETF to perform well in the short-term.

How to buy Direxion Daily S&P Biotech Bear 3X ETF ETF?
Direxion Daily S&P Biotech Bear 3X ETF ETF can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Direxion Daily S&P Biotech Bear 3X ETF ETF.

What's the current price of Direxion Daily S&P Biotech Bear 3X ETF ETF?
As of the end of day on the 2024-04-18, the price of an Direxion Daily S&P Biotech Bear 3X ETF (LABD) share was $10.52.

What is the 52-week high and low for Direxion Daily S&P Biotech Bear 3X ETF ETF?
The 52-week high for Direxion Daily S&P Biotech Bear 3X ETF ETF is $29.88 and the 52-week low is $5.72.

What is the market capitalization of Direxion Daily S&P Biotech Bear 3X ETF ETF?
As of the 2024-04-18, the market capitalization of Direxion Daily S&P Biotech Bear 3X ETF is 142.59M.
Click to get the best stock tips daily for free!

About Direxion Daily S&P Biotech Bear 3X ETF

LABD was created on 05/28/15 by Direxion. The ETF provides daily 3 times exposure to the S&P Biotechnology Select Industry Index.... LABD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT